Sovaldi and Zofran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sovaldi (sofosbuvir) and Zofran (ondansetron hydrochloride). Common drug interactions include sleep apnoea syndrome among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Sovaldi and Zofran. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Sovaldi?

Sovaldi has active ingredients of sofosbuvir. eHealthMe is studying from 12,697 Sovaldi users. Check the latest studies of Sovaldi.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.



On Jul, 14, 2026

37 people who take Sovaldi and Zofran together, and have interactions are studied.

Sovaldi and Zofran drug interactions.

What are the common drug interactions of Sovaldi and Zofran, by gender? *:

female:

  1. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  2. Abdominal pain
  3. Abdominal pain upper
  4. Arthralgia (joint pain)
  5. Atrioventricular block second degree (heart block second degree)
  6. Confusional state
  7. Dehydration (dryness resulting from the removal of water)
  8. Dysgeusia (disorder of the sense of taste)
  9. Dyspnoea (difficult or laboured respiration)
  10. Electrocardiogram qt prolonged

male:

  1. Headache (pain in head)
  2. Abdominal distension
  3. Dyspnoea (difficult or laboured respiration)
  4. Injection site rash
  5. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  6. Pruritus (severe itching of the skin)
  7. Suicidal ideation
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Abdominal pain
  10. Abdominal pain upper

What are the common drug interactions of Sovaldi and Zofran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pain
  2. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

30-39:

  1. Anaemia (lack of blood)
  2. Depression
  3. Fatigue (feeling of tiredness)
  4. Headache (pain in head)
  5. Injection site pruritus (severe itching at injection site)
  6. Injection site rash
  7. Leukopenia (less number of white blood cells in blood)
  8. Suicidal ideation
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Abdominal pain

40-49:

  1. Pyrexia (fever)
  2. Autoimmune hepatitis
  3. Cough
  4. Decreased appetite
  5. Diarrhoea
  6. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  7. Dysuria (painful or difficult urination)
  8. Fatigue (feeling of tiredness)
  9. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  10. Ocular icterus (presence of jaundice seen in the sclera of the eye)

50-59:

  1. Anaemia (lack of blood)
  2. Angina pectoris (chest pain due to ischemia of the heart muscle)
  3. Blood bilirubin increased
  4. Blood iron increased
  5. Cardiac disorder
  6. Chest pain
  7. Chronic kidney disease
  8. Drug ineffective
  9. Dysgeusia (disorder of the sense of taste)
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Abdominal pain upper
  2. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  3. Ammonia increased
  4. Aphagia (inability or refusal to swallow)
  5. Appetite disorder (abnormal eating habits)
  6. Arthralgia (joint pain)
  7. Asthenia (weakness)
  8. Bone pain
  9. Confusional state
  10. Dry skin

What are the existing conditions these people have? *

  1. Hepatitis C: 25 people, 67.57%
  2. Depression: 6 people, 16.22%
  3. Urination - Painful: 4 people, 10.81%
  4. Stress And Anxiety: 4 people, 10.81%
  5. Pain: 4 people, 10.81%
  6. Autoimmune Hepatitis: 4 people, 10.81%
  7. Sleep Disorder: 3 people, 8.11%
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 8.11%
  9. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 8.11%
  10. Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Sovaldi and Zofran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sovaldi and Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sovaldi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sovaldi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sofosbuvir and ondansetron hydrochloride (the active ingredients of Sovaldi and Zofran, respectively), and Sovaldi and Zofran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: